Advanced Cell Technology’s Dr. Robert Lanza to Deliver the Keynote Address at Brigham and Women's Hospital Regenerative Medicine Center Inaugural Symposium
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that its chief scientific officer, Robert Lanza, M.D., will be delivering the Keynote Address at the BWH Regenerative Medicine Center Inaugural Symposium, being held at Brigham & Women’s Hospital in Boston on June 11. The Symposium will showcase an exciting array of research in regenerative medicine; highlighting the work of both nationally and internationally recognized investigators and that of the rising stars working in this domain. Dr. Lanza’s address, titled “Pluripotent Stem Cells – Moving From Bench to Bedside,” will take place at 4 p.m. EDT in the Bornstein Family Amphitheater & Cabot Atrium.
Help employers find you! Check out all the jobs and post your resume.
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that its chief scientific officer, Robert Lanza, M.D., will be delivering the Keynote Address at the BWH Regenerative Medicine Center Inaugural Symposium, being held at Brigham & Women’s Hospital in Boston on June 11. The Symposium will showcase an exciting array of research in regenerative medicine; highlighting the work of both nationally and internationally recognized investigators and that of the rising stars working in this domain. Dr. Lanza’s address, titled “Pluripotent Stem Cells – Moving From Bench to Bedside,” will take place at 4 p.m. EDT in the Bornstein Family Amphitheater & Cabot Atrium.
Help employers find you! Check out all the jobs and post your resume.